ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	50.82	70.97	210.52	60.06	24.52
Short-Term Investments	263.21	157.39	63.86	-	-
Cash & Short-Term Investments	314.02	228.36	274.38	60.06	24.52
Cash Growth	37.51%	-16.77%	356.82%	144.94%	-
Accounts Receivable	8.18	-	-	-	0.38
Other Receivables	0.99	0.69	1.01	0	0
Receivables	9.16	0.69	1.01	0	0.38
Inventory	5.21	-	-	-	-
Prepaid Expenses	4.67	2.03	2.31	0.67	1.48
Other Current Assets	1.23	0.65	-	-	-
Total Current Assets	334.3	231.73	277.7	60.73	26.38
Property, Plant & Equipment	1.07	0.82	0.77	0.69	0.02
Other Intangible Assets	7.69	0.62	-	-	-
Other Long-Term Assets	8.11	0.02	2.96	0.02	0
Total Assets	351.15	233.19	281.44	61.45	26.41
Accounts Payable	14.13	0.76	1.66	1.79	1.22
Accrued Expenses	4.15	0.36	2.1	1.3	0.84
Current Portion of Long-Term Debt	-	-	-	3.48	2.56
Current Portion of Leases	0.04	0.24	0.23	0.14	-
Current Income Taxes Payable	-	-	0.17	-	-
Current Unearned Revenue	0.56	-	0.28	1.46	3.52
Other Current Liabilities	4.57	1.04	1	0.02	0.08
Total Current Liabilities	23.44	2.39	5.44	8.19	8.21
Long-Term Debt	69.38	-	-	4.93	7.46
Long-Term Leases	-	0.04	0.25	0.48	-
Long-Term Unearned Revenue	1.53	-	2.85	3	3.44
Other Long-Term Liabilities	-	-	-	0.08	0.11
Total Liabilities	94.36	2.43	8.55	16.68	19.23
Common Stock	0.01	0.01	0.01	0	0.22
Additional Paid-In Capital	379.87	362	349.41	10.98	7.74
Retained Earnings	-123.31	-131.3	-76.94	-42.26	-22.01
Comprehensive Income & Other	0.22	0.05	0.41	-	-
Total Common Equity	256.8	230.76	272.89	-31.27	-14.05
Shareholders' Equity	256.8	230.76	272.89	44.77	7.18
Total Liabilities & Equity	351.15	233.19	281.44	61.45	26.41
Total Debt	69.43	0.27	0.48	9.03	10.02
Net Cash (Debt)	244.6	228.09	273.9	51.03	14.5
Net Cash Growth	7.24%	-16.73%	436.74%	251.86%	-
Net Cash Per Share	2.39	2.40	6.86	1.77	0.72
Filing Date Shares Outstanding	98.12	96.5	94.4	25.7	20.22
Total Common Shares Outstanding	97.95	96.41	93.94	25.7	20.22
Working Capital	310.86	229.34	272.26	52.54	18.17
Book Value Per Share	2.62	2.39	2.90	-1.22	-0.70
Tangible Book Value	249.11	230.14	272.89	-31.27	-14.05
Tangible Book Value Per Share	2.54	2.39	2.90	-1.22	-0.70
Machinery	1.21	0.67	0.38	0.09	0.03
Leasehold Improvements	0.02	0.02	-	-	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q